Bagert B - Search Results

Year	Number of Results
2002	2
2006	2
2007	1
2009	2
2011	2
2019	2
2020	1
2022	1
2024	0

1

Gadolinium Deposition in Neurology Clinical Practice.

Smith TE, Steven A, Bagert BA. Smith TE, et al. Among authors: bagert ba. Ochsner J. 2019 Spring;19(1):17-25. doi: 10.31486/toj.18.0111. Ochsner J. 2019. PMID: 30983897 Free PMC article. Review.

2

Spinal Dural Arteriovenous Fistula: The Missing-Piece Sign.

Kelley M, April D, Bagert B, Milburn J, Steven A. Kelley M, et al. Among authors: bagert b. Ochsner J. 2022 Spring;22(1):10-14. doi: 10.31486/toj.21.0110. Ochsner J. 2022. PMID: 35355649 Free PMC article. No abstract available.

3

Chronic cerebrospinal venous insufficiency and multiple sclerosis.

Bagert BA, Marder E, Stüve O. Bagert BA, et al. Arch Neurol. 2011 Nov;68(11):1379-84. doi: 10.1001/archneurol.2011.179. Epub 2011 Jul 11. Arch Neurol. 2011. PMID: 21747006 Review.

4

Epstein-Barr virus in multiple sclerosis.

Bagert BA. Bagert BA. Curr Neurol Neurosci Rep. 2009 Sep;9(5):405-10. doi: 10.1007/s11910-009-0059-9. Curr Neurol Neurosci Rep. 2009. PMID: 19664371 Review.

5

Cognition and fatigue in multiple sclerosis: Potential effects of medications with central nervous system activity.

Oken BS, Flegal K, Zajdel D, Kishiyama SS, Lovera J, Bagert B, Bourdette DN. Oken BS, et al. Among authors: bagert b. J Rehabil Res Dev. 2006 Jan-Feb;43(1):83-90. doi: 10.1682/jrrd.2004.11.0148. J Rehabil Res Dev. 2006. PMID: 16847774 Free article. Review.

6

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.

Bagert B, Camplair P, Bourdette D. Bagert B, et al. CNS Drugs. 2002;16(7):445-55. doi: 10.2165/00023210-200216070-00002. CNS Drugs. 2002. PMID: 12056920 Review.

7

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient With Antithyroid Peroxidase Antibodies and a Parotid Pleomorphic Adenoma.

Sitterley K, von Kleist T, Bagert BA. Sitterley K, et al. Among authors: bagert ba. Ochsner J. 2019 Spring;19(1):59-62. doi: 10.31486/toj.18.0115. Ochsner J. 2019. PMID: 30983904 Free PMC article.

8

Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests.

Lovera J, Bagert B, Smoot KH, Wild K, Frank R, Bogardus K, Oken BS, Whitham RH, Bourdette DN. Lovera J, et al. Among authors: bagert b. J Rehabil Res Dev. 2006 Jan-Feb;43(1):73-82. doi: 10.1682/jrrd.2004.09.0118. J Rehabil Res Dev. 2006. PMID: 16847773 Free article.

9

Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial.

Lovera J, Bagert B, Smoot K, Morris CD, Frank R, Bogardus K, Wild K, Oken B, Whitham R, Bourdette D. Lovera J, et al. Among authors: bagert b. Mult Scler. 2007 Apr;13(3):376-85. doi: 10.1177/1352458506071213. Epub 2007 Jan 29. Mult Scler. 2007. PMID: 17439907 Clinical Trial.

10

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD; SPI2 investigative teams. Cree BAC, et al. Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23. Lancet Neurol. 2020. PMID: 33222767 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year